SecBot SecBot

ICUI

ICU MEDICAL INC
Nasdaq· Surgical & Medical Instruments & Apparatus· Inc. DE· CIK 0000883984 Healthcare & Medical Devices
$166.39 +3.19 (+1.95%)
Oct 28 4:00 PM ET · prev $163.20
Market cap
$4.2B
Mid cap
Consensus
Buy
92% Buy or better · 13 analysts
Median target
🔒 Subscribers only
Next earnings
Nov 5
in 8 days
1 year
+41.4%
from $117.67 · Oct 29
30 days
+1.8%
from $163.44
52-week range
$115.45–187.26
−11% from high · low Apr 29
Avg volume 20D
217.2K
shares / day
Short interest
1.71M
≈6.8% of shares · +12.5%
Days to cover
7.8
at average volume
Insider net
−$7.5M
0 buyers · 7 sellers · since Mar 15
New fund stakes
0
Q2 2026 13F · 0 exits
SecBot read MIXED 5 reports · 90 days
Balance 1 bearish · 0 bullish · 4 neutral oldest → newest, height = score
Avg score ·High conf. 2/5 ·Next Earnings date, Nov 5, 2026
Strongest NEUTRAL Two C-suite insiders at ICU Medical (CFO and VP/General Counsel) sold a combined $1.49M in open-market sales…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

  • S May 12 to May 14 2 days of insider sells: $601.6K by 2 insiders, avg $123.50
  • S May 22 1 insider sell $280.7K at $132.21
  • A May 27 Needham upgrades
  • A Jun 15 BTIG initiates
  • S Aug 11 to Aug 13 3 days of insider sells: $3.1M by 4 insiders, avg $181.80
  • S Aug 31 to Sep 3 3 days of insider sells: $3.5M by 2 insiders, avg $172.51

Signal stack

Where each data set points today.

  • InsidersBEARISH

    7 insiders sold $7.5M.

  • InstitutionsMIXED

    Q2 2026: 19 added (0 new), 17 trimmed or exited.

  • AnalystsBULLISH

    12 of 13 rate it Buy or better.

  • Short sellersSTEADY

    Short interest +12.5% to 1.71M shares. 7.8 days to cover, ≈6.8% of shares.

  • TrendUPTREND

    1% above its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
CITADEL ADVISORS LLCADD536,225$78.6M
GOLDMAN SACHS GROUP INCADD417,342$61.2M
MORGAN STANLEYTRIM372,583$54.6M
TORONTO DOMINION BANKADD358,023$52.5M
NORGES BANKTRIM177,733$26.1M
Point72 Asset Management, L.P.ADD165,469$24.3M
Quantinno Capital Management LPTRIM158,642$23.3M
WELLINGTON MANAGEMENT GROUP LLPTRIM148,986$21.8M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

13 analysts
Buy 92% rate it Buy or better
Strong Buy5Buy7Hold1Sell0Strong Sell0

Fresh Price Targets

Analyst price targets updated within the last 24 hours are for subscribers only.

Subscribe for Full Access
Recent actions
DateFirmActionRating
Aug 7, 2026Piper Sandler
MAINTAIN
MAINTAINOverweight
Aug 7, 2026BTIG
MAINTAIN
MAINTAINBuy
Aug 7, 2026Needham
MAINTAIN
MAINTAINBuy
Jul 21, 2026Keybanc
MAINTAIN
MAINTAINOverweight
Jun 15, 2026BTIG
INITIATE
INITIATEBuy
May 27, 2026Needham
UPGRADE
UPGRADEBuy

Insider ledger

Form 4
$0
bought · 0 insiders
$7.5M
sold · 7 insiders
DateInsiderTypeValue
Sep 3, 2026
Sanzone Virginia Ruth
VP, General Counsel
SELL$208.5K
Sep 3, 2026
Sanzone Virginia Ruth
VP, General Counsel
SELL$118.7K
Sep 3, 2026
Sanzone Virginia Ruth
VP, General Counsel
SELL$122.7K
Sep 3, 2026
Sanzone Virginia Ruth
VP, General Counsel
SELL$369.2K
Sep 1, 2026
Bonnell Brian Michael
Chief Financial Officer
SELL$1.1M
Aug 31, 2026
Bonnell Brian Michael
Chief Financial Officer
SELL$193.6K
Aug 31, 2026
Bonnell Brian Michael
Chief Financial Officer
SELL$292.8K
Aug 31, 2026
Bonnell Brian Michael
Chief Financial Officer
SELL$792.3K

Earnings setup

Estimates
Nov 5
reports in 8 days

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Short side

FINRA· Oct 15, 2026
1,712,861
shares short
+12.5%
vs prior settlement
7.8
days to cover
≈6.8%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Oct 22, 2026 SEC
ICU Medical, Inc. announced it will host a conference call to discuss its Q3 2026 results.
PRESS-RELEASE · Impact 1/10
Oct 22, 2026 Earnings
ICU Medical Announces Time of Third Quarter 2026 Earnings Conference Call
SAN CLEMENTE, Calif., Oct. 22, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader i
Oct 16, 2026 Event
DEXTROSE
Unavailable: Product discontinued. This product is distributed by ICU Medical. For questions regardi
Sep 3, 2026 SEC
Two C-suite insiders at ICU Medical (CFO and VP/General Counsel) sold a combined $1.49M in open-market sales over a…
CLUSTER · Impact 4/10
Sep 3, 2026 Insider
Sanzone Virginia Ruth sold 1,238 shares
VP, General Counsel @ $168.44 ($208.5K)
Sep 3, 2026 Insider
Sanzone Virginia Ruth sold 692 shares
VP, General Counsel @ $171.52 ($118.7K)
Sep 3, 2026 Insider
Sanzone Virginia Ruth sold 724 shares
VP, General Counsel @ $169.53 ($122.7K)
Aug 13, 2026 SEC
Four ICUI insiders, including the COO and VP-GM of Infusion Capital, sold a total of ~$3.09M in open-market sales over…
CLUSTER · Impact 5/10
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 5, 2026
Earnings date
ICUI Q3 2026 Earnings Scheduled · 2026-11-05
Recent
Oct 22, 2026
Earnings
ICU Medical Announces Time of Third Quarter 2026 Earnings Conference Call
SAN CLEMENTE, Calif., Oct. 22, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of…
Oct 16, 2026
FDA
DEXTROSE
Unavailable: Product discontinued. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical. (Disc
Oct 16, 2026
FDA
AMINOSYN-PF
Unavailable: Estimated recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical. (S
Oct 16, 2026
FDA
AMINOSYN-PF
Unavailable: Estimated recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical. (S
Sep 16, 2026
FDA
AMINOSYN-PF
Unavailable: Estimated recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical. (S

SecBot reports

7 filings · 0 bullish · 1 bearish · 6 neutral
All ICUI filing & press-release reports (7)